Towa Pharmaceutical Co Ltd banner

Towa Pharmaceutical Co Ltd
TSE:4553

Watchlist Manager
Towa Pharmaceutical Co Ltd Logo
Towa Pharmaceutical Co Ltd
TSE:4553
Watchlist
Price: 4 175 JPY 0.36% Market Closed
Market Cap: ¥205.5B

Intrinsic Value

The intrinsic value for Towa Pharmaceutical Co Ltd (4553) under the Base Case is 3 812.11 JPY. Compared with the current market price of 4 175 JPY, the stock appears Overvalued by 9%.

Based on two methods:

DCF suggests overvaluation, while multiples suggest undervaluation.

Intrinsic Value
3 812.11 JPY
Overvaluation 9%
Intrinsic Value
Price ¥4 175
Base Case Scenario
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value ¥3 049.69
Get notified when the price drops into your buy zone
Current Price ¥4 175
Intrinsic Value ¥3 812.11
Margin of Safety 20% ¥3 049.69
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about Towa Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Towa Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Towa Pharmaceutical Co Ltd.

Explain Valuation
Alternatives to Towa Pharmaceutical Co Ltd

Wall St
Price Targets

Dividends

Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one Towa Pharmaceutical Co Ltd stock?

The intrinsic value for Towa Pharmaceutical Co Ltd (4553) under the Base Case is 3 812.11 JPY.

Is Towa Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared with the current market price of 4 175 JPY, the stock appears Overvalued by 9%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett